Metastatic Breast Cancer
Metastatic breast cancer occurs when breast cancer cells spread beyond the breast to other parts of the body, such as the bones, liver, or lungs, often leading to more severe symptoms and requiring advanced treatment.
Breast Cancer Treatment: Fulvestrant with Palbociclib
We are studying whether combining fulvestrant with palbociclib helps postmenopausal women with hormone receptor-positive metastatic breast cancer live longer without disease progression compared to fulvestrant alone. This trial is for women who have completed at least five years of hormonal therapy and remained disease-free for over a year, or who have newly diagnosed metastatic disease.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have breast cancer that has spread (metastatic disease)?
- Are you currently taking any medications that are known to be strong inhibitors or inducers of CYP3A4?
- Do you have any severe heart problems or a history of long QT syndrome?
- Have you had any other cancer in the last 5 years, other than breast cancer or certain skin cancers?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Afultrant
Ambiful
Falvax
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Bon Secours Hospital Cork
Oncology
Cork, Ireland
University Hospital Waterford
Oncology
Waterford, Ireland
Fundacion Centro Oncologico Regional De Galicia Jose Antonio Quiroga Y Pineyro
Oncology
A Coruña, Spain
Sponsor: Fundacion Grupo Espanol De Investigacion En Cancer De Mama
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.